World Molecular Diagnostics Market Insights and Forecasts 2020-2024 with COVID-19 Impact Analysis

DUBLIN, Sept. 15, 2020 /PRNewswire/ -- The "Global Molecular Diagnostics Market (by Application, Technology, End-Use & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

The global molecular diagnostics market is estimated to reach US$17.96 billion in 2024, growing at a CAGR of 6.16% for the period spanning from 2020 to 2024. The factors such as rising emergence of infectious diseases rise in global ageing population, increasing incidence of cancer cases are expected to drive the market. However, growth of the industry will be challenged by high initial cost, dearth of trained professionals, urgent need for proper infrastructure and delay in the approval of new molecular diagnostic tests. A few notable trends include progressing sample-to-answer molecular diagnostics market, growth in point of care diagnostics, booming medical devices industry, innovation and technical developments, emergence of liquid biopsy solutions, targeting anti-biotic resistance, decentralization of diagnostic testing, advances in genomics and proteomics.

The global molecular diagnostics market is segmented into, infectious diseases, oncology, genetics, blood screening, and tissue typing.

The global molecular diagnostics market is expected to grow in future mainly due to diagnosis of infectious diseases. In terms of geographical areas, North America is the major contributors to the global molecular diagnostics market supported by rising spread of infectious diseases and presence of a well-established diagnostic infrastructure, technological advancements. Asia Pacific represents the fastest growing market for molecular diagnostics with rapidly developing infrastructure and increasing investments in research and development.

Scope of the report:

• The report provides a comprehensive analysis of the global molecular diagnostics market, segmented into, infectious diseases, oncology, genetics, blood screening, and tissue typing.
• The major regional markets (North America, Western Europe and Asia Pacific) have been analyzed.
• The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
• The competitive landscape of the market, along with the company profiles of leading players (Roche Holding AG, Abbott Laboratories, Danaher Corporation, Hologic Inc., Biomerieux SA and Thermo Fisher Scientific Inc.) are also presented in detail.

Key Topics Covered:

1. Overview
1.1 Diagnostics
1.2 Molecular Diagnostics
1.3 Purpose of Molecular Diagnostics

2. Molecular Diagnostics in COVID-19 Testing
2.1 COVID-19 Diagnostics
2.2 Molecular Diagnostics for COVID-19
2.3 Molecular Diagnostics Test Vendors
2.4 COVID-19 Test in Development
2.5 COVID-19 Molecular Diagnostics Test Kit Production Capacity

3. Global Molecular Diagnostics Market
3.1 Global Molecular Diagnostics Market by Value
3.2 Global Molecular Diagnostics Market Forecast by Value
3.3 Global Molecular Diagnostics Market by Application
3.4 Global Molecular Diagnostics Market by Technology
3.5 Global Molecular Diagnostics Market by End Use

4. Regional Market Analysis
4.1 North America
4.2 Western Europe
4.3 Asia Pacific

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Emergence of Infectious Diseases
5.1.2 Rise in Global Ageing Population
5.1.3 Increasing Incidence of Cancer Cases
5.2 Key Trends and Developments
5.2.1 Progressing Sample-to-Answer Molecular Diagnostics Market
5.2.2 Growth in Point of Care Diagnostics (POCT)
5.2.3 Booming Medical Devices Industry
5.2.4 Innovation and Technical Developments
5.2.5 Emergence of Liquid Biopsy Solutions
5.2.6 Targeting Anti-Biotic Resistance
5.2.7 Decentralization of Diagnostic Testing
5.2.8 Advances in Genomics and Proteomics
5.3 Challenges
5.3.1 High Initial Cost
5.3.2 Dearth of Trained Professionals
5.3.3 Urgent Need for Proper Infrastructure
5.3.4 Delay in the Approval of New Molecular Diagnostic Tests

6. Competitive Landscape
6.1 Global IVD Market
6.1.1 Global IVD Kit Market Share by Company
6.2 Global Molecular Diagnostics Market
6.2.1 Global Molecular Diagnostics Market Share by Company
6.2.2 Global Infectious Disease Testing Market Share by Company
6.2.3 Global Blood Screening Testing Market Share by Company
6.2.4 Revenue and Market Cap Comparison

7. Company Profiles

• Roche Holding AG
• Abbott Laboratories
• Danaher Corporation
• Hologic Inc.
• Biomerieux SA
• Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/qz3fn7

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets